Gastrointestinal Cancer
From the Journals
Number of cancer survivors with functional limitations doubled in 20 years
The 70% prevalence of functional limitation among survivors in 2018 is nearly twice that of the general population.
From the Journals
New AI tool may help predict best treatments for colorectal cancer
The tool is not yet ready for clinical use. When it is, the tool has the potential to provide timely, accurate decision support based on tumor...
Conference Coverage
CRC screening rates are higher in Medicaid expansion states
Medicaid expansion may be a determinant of whether screening is even offered.
From the Journals
Familial cancer risk complex, not limited to same site
“The findings suggest that the familial risk extends to discordant early-onset cancers, including ovarian, testicular, and pancreatic cancers, as...
From the Journals
H. pylori eradication therapy curbs risk for stomach cancer
The study is significant because “it is the first to show this effect in a large, diverse population in the U.S., where gastric cancer incidence...
From the Journals
Study shows higher obesity-related cancer mortality in areas with more fast food
An ecologic study showed a dose-response relationship among measures of food swamp and food desert scores and obesity-related cancer mortality.
Conference Coverage
Expert discusses which diets are best, based on the evidence
The Mediterranean diet is not only helpful for losing weight but also can reduce the risk of various chronic diseases.
From the Journals
Cancer pain declines with cannabis use
Lower use of other meds was also seen in patients who used cannabis.
From the Journals
The next big thing in cancer research
Despite significant progress, there is still a lot of work to do.
Conference Coverage
Drug combo improves recurrence-free survival after HCC resection
Study shows significant improvement in recurrence-free survival with atezolizumab and bevacizumab combo.
Conference Coverage
Liver transplants for CRC metastases: Coming into its own?
Transplantation is emerging as an attractive option for select patients with nonresectable CRC liver metastases, and patients with intrahepatic...